In an elderly woman with depression, which medication is preferred: desvenlafaxine (Pristiq) or bupropion sustained-release (Wellbutrin SR)?

Bupropion SR (Wellbutrin SR) is the preferred choice for depression in an elderly woman

For an elderly woman with depression, bupropion SR (Wellbutrin SR) should be selected over desvenlafaxine (Pristiq) based on established guideline recommendations specifically addressing geriatric populations. 1

Guideline-Based Recommendation for Elderly Patients

The 2015 American Family Physician guidelines explicitly list preferred agents for older patients with depression, which include:

• Citalopram
• Escitalopram
• Sertraline
• Mirtazapine
• Venlafaxine
• Bupropion 1

Notably, desvenlafaxine (Pristiq) is not included in this preferred list for elderly patients. While desvenlafaxine is an SNRI like venlafaxine, the guidelines specifically recommend venlafaxine but do not extend this recommendation to desvenlafaxine for geriatric populations.

Key Advantages of Bupropion SR in Elderly Women

Favorable Side Effect Profile

• No sexual dysfunction: Bupropion has significantly lower rates of sexual adverse events compared to SSRIs and SNRIs 2
• No weight gain: Unlike many antidepressants, bupropion does not cause weight gain 2
• Activating properties: Tends to reduce apathy and improve energy levels, which can be beneficial in elderly patients 3
• Lower somnolence: Less sedation compared to other antidepressants 2

Safety Considerations in Elderly

• Dose adjustment needed: Start at approximately 50% of adult starting dose (37.5 mg every morning, increasing by 37.5 mg every 3 days) 3
• Maximum dose: 150 mg twice daily 3
• Timing: Give second dose before 3 p.m. to minimize insomnia risk 3
• Renal/hepatic disease: Dose reduction required in both conditions 1

Evidence of Efficacy in Elderly

A head-to-head trial specifically in elderly patients (≥60 years, range 60-88 years) demonstrated that bupropion SR was equally effective as paroxetine for treating major depression, with both groups showing improved scores on all depression rating scales 4. The study concluded bupropion SR provides "a safe and effective nonserotonergic treatment alternative that is well suited as an antidepressant for the elderly" due to its favorable side effect profile 4.

Concerns with Desvenlafaxine in Elderly

Limited Geriatric-Specific Evidence

• Desvenlafaxine is not listed among preferred agents for elderly patients in established guidelines 1
• While venlafaxine (the parent compound) is recommended, this recommendation does not automatically extend to desvenlafaxine
• The evidence for desvenlafaxine in elderly populations is less robust than for bupropion 5

SNRI-Related Adverse Effects

• Higher nausea/vomiting rates: SNRIs, including desvenlafaxine, have higher rates of gastrointestinal side effects 1
• Discontinuation syndrome risk: Requires careful tapering 5
• Blood pressure monitoring: Requires regular monitoring for elevated blood pressure 6
• Hyponatremia risk: SNRIs carry risk of hyponatremia, particularly concerning in elderly patients 2

Important Contraindications and Precautions for Bupropion

Absolute Contraindications

• Seizure disorders: Should not be used in patients with seizure history 3
• Agitated patients: Should be avoided 3
• Eating disorders: Contraindicated in bulimia/anorexia due to increased seizure risk

Monitoring Requirements

• Seizure risk minimization: Use twice-daily dosing with at least 8 hours between doses when exceeding 150 mg/day 7
• Alcohol use: Minimize or avoid alcohol; abrupt discontinuation of alcohol increases seizure risk 7
• Benzodiazepine use: Abrupt discontinuation increases seizure risk 7

Clinical Algorithm for Decision-Making

Choose Bupropion SR if:

• No history of seizures
• No current eating disorder
• Patient has apathy, low energy, or psychomotor retardation
• Concerns about sexual dysfunction or weight gain
• Patient prefers activating rather than sedating medication

Consider Desvenlafaxine instead if:

• History of seizures (absolute contraindication to bupropion)
• Severe agitation present
• Comorbid chronic pain conditions (SNRIs have analgesic properties) 5
• Patient specifically failed bupropion previously

Dosing Strategy for Elderly Woman

Bupropion SR initiation:

1. Start: 37.5 mg every morning
2. Increase by 37.5 mg every 3 days as tolerated
3. Target: 150 mg twice daily (maximum dose)
4. Give second dose before 3 p.m. to prevent insomnia
5. Ensure at least 8 hours between doses when exceeding 150 mg/day total

Common pitfall to avoid: Do not use three-times-daily dosing in elderly patients; the sustained-release formulation allows for twice-daily dosing, improving adherence and reducing seizure risk 7.

The evidence strongly supports bupropion SR as the preferred first-line choice for this elderly woman, based on explicit guideline recommendations, favorable tolerability profile, and specific evidence of efficacy and safety in geriatric populations 1, 4.